Processa Pharmaceuticals, Inc. (PCSA)
Nasdaq: PCSA · Pharmaceutical Preparations · Vero Beach, FL · filing with the SEC since 2011
Who owns Processa Pharmaceuticals, Inc.
As filed with the SECHolders of 5% or more
4
HX Entertainment Ltd holds 13% of Common Stock, par value $0.0001 per share, as its SCHEDULE 13D/A filed Feb 23, 2026 says.
Directors and officers
11
report now, of 15 people on the record since 2020. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
HX Entertainment Ltd
SCHEDULE 13D/A · filed Feb 23, 2026 · Common Stock, par value $0.0001 per share · 10.9% in Oct 15, 2025
Mitchell P. Kopin
SCHEDULE 13G/A · filed Feb 13, 2026 · Common stock, par value $0.0001 per share · 9.99% in Aug 12, 2025
CVI Investments, Inc.
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, $0.0001 par value per share · 9% in Nov 7, 2025
Soleus Capital Master Fund, L.P.
SCHEDULE 13G · filed Aug 18, 2026 · Common Stock, par value $0.0001 per share
Armistice Capital, LLC
SCHEDULE 13G/A · filed Aug 14, 2025 · Common Stock, $0.0001 par value per share · reported falling below 5%, from 9.99% in May 15, 2025
3i, LP
SCHEDULE 13G · filed Jun 23, 2025 · Common Stock, par value $0.0001 per share · reported falling below 5%
What PCSA reports owning in othersstakes of 5% or more, and other ties
1 subsidiary in 1 country, from the list filed with the 10-K filed Mar 18, 2026.
Insider tradesForm 4
0sales
45purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$200,000bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window9 of 16 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Ng George K | Chief Executive Officer | 0 | $0 | 0 | 10 | $100,000 |
| Skibsted Russell | Chief Financial Officer | 0 | $0 | 0 | 7 | $0 |
| Guy Wendy | Chief Administrative Officer | 0 | $0 | 0 | 7 | $0 |
| Lin Patrick | Chief Business - Strategy Off | 0 | $0 | 0 | 7 | $0 |
| Young David | Pres. Research & Development | 0 | $0 | 0 | 7 | $0 |
| Bigora Sian | Chief Development Officer | 0 | $0 | 0 | 4 | $0 |
| Baluch Khoso | director | 0 | $0 | 0 | 1 | $0 |
| Neal James R | director | 0 | $0 | 0 | 1 | $0 |
| Pannu Geraldine | director | 0 | $0 | 0 | 1 | $0 |